Alnylam Pharmaceuticals | ALNY - Текущие активы





Текущие активы Изменить Дата
Acadia Pharmaceuticals USD 1.22B 128.53M 2026-06
Agios Pharmaceuticals USD 717.67M 117.18M 2026-06
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
Amgen USD 34.96B 3.49B 2026-06
Arrowhead Research USD 1.67B 168.34M 2026-06
BioCryst Pharmaceuticals USD 484.68M 111.06M 2026-06
BioMarin Pharmaceutical USD 3.92B 50.99M 2026-09
Incyte USD 5.52B 505.2M 2026-09
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
Moderna USD 5.82B 45M 2026-06
Neurocrine Biosciences USD 2.01B 370.7M 2026-09
Novartis USD 28.75B 2.14B 2026-09
PTC Therapeutics USD 2.54B 79.58M 2026-09
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sanofi EUR 31.52B 1.36B 2026-06
Sarepta Therapeutics USD 2.22B 86.05M 2026-06
Takeda JPY 3T 153.11B 2026-09
Tectonic Therapeutic USD 231.1M 8.79M 2026-06
Ultragenyx Pharmaceutical USD 606M 51M 2026-06
Vertex Pharmaceuticals USD 11.69B 857.4M 2026-09
Xencor USD 523.21M 40.36M 2026-06